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Our previous papers described a protein called spot 35 found in the cerebellar cytosol of adult rats by two- 
dimensional gel electrophoresis and localized in the Purkinje cells by immunohistochemical methods. Here 
we describe the biosynthesis of this spot 35 protein using a reticulocyte lysate cell-free system containing 
rat cerebellar mRNA. The developmental changes of mRNA-dependent protein biosynthesis were also 
examined. During postnatal 10-30 days, a rapid increase of mRNA levels for spot 35 protein was observed. 
The application of the new 45Ca-binding assay procedure revealed that this protein is a Ca-binding protein. 
Cerebellar protein mRNA 
1. INTRODUCTION 
In a previous paper, Yoshida and Takahashi [l] 
described the developmental changes of soluble 
proteins in the rat cerebral mantle, cerebellum and 
brain stem using two-dimensional gel electro- 
phoresis. They found a protein called spot 35 pro- 
tein with pl around 5.3 and MI around 27 000, that 
appears in the adult cerebellum but does not ap- 
pear in fetal and newborn rats. Yamakuni et al. [2] 
isolated this protein and made an antibody against 
it. Furthermore, the immunohistochemical ex- 
amination of spot 35 protein revealed its localiza- 
tion in Purkinje cells. Since this localization was 
very interesting, we attempted to characterize the 
properties of the protein and observe the develop- 
mental changes of mRNA levels in the rat cere- 
bellum. 
2. MATERIALS AND METHODS 
2.1. Preparation of spot 35 protein and its 
antiserum 
The isolation of spot 35 protein and the prepara- 
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tion of its antisera were previously described. 
Briefly, bovine cerebellum (200 g) was homoge- 
nized in 5 vols of 20 mM Tris-HCl buffer (pH 7.4) 
containing 0.32 M sucrose and the homogenate 
was centrifuged at 10’ xg for 90 min. After solid 
ammonium sulfate was added to the supernatant 
to achieve 85% saturation, the suspension was stir- 
red for 24 h and recentrifuged at 16 000 x g for 40 
min. To the resulting supernatant, solid am- 
monium sulfate was added to achieve 100% 
saturation. The resulting precipitated protein con- 
tained the spot 35 protein. Further purification of 
this protein was achieved by 2 cycles of DEAE- 
Sephadex A50 column chromatography. However, 
the protein fraction still contained about 10% con- 
taminant proteins, according to SDS-polyacryl- 
amide gel electrophoresis (SDS-PAGE). There- 
fore, 1.0-l .5 mg of this protein fraction was ap- 
plied to a preparative slab SDS-PAGE (12.5%) 
and the protein band corresponding to spot 35 was 
cut from the gel and the protein extracted elec- 
trophoretically. Antiserum was prepared by sub- 
cutaneous injection of the purified protein (250, 
250, 400 and 4OOpg) mixed with Freund complete 
adjuvant to a rabbit once a fortnight. The 
Ouchterlony double diffusion technique was used 
for the antiserum analysis. 
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2.2. 45Ca-binding assay 
This assay was carried out according to Maruy- 
ama et al. [3] with a slight modification. Briefly, 
after the proteins were separated using SDS-PAGE 
(S- 18% gradient gel), the proteins were transferred 
onto a nitrocellulose membrane by electroblotting. 
The membrane was soaked in a solution containing 
5 mM MgClz, 60 mM KC1 and 10 mM imidazole- 
HCL (pH 6.8). Then the membrane was incubated 
in 25 ml of the same buffer solution containing 
45CaC12 (1 mCi/l) for 10 min and then rinsed in 
50% ethanol solution for 5 min. The membrane 
was dried at room temperature for 3 h and then 
subjected to autoradiography. . 
2.3. Isolation of rat brain mRNA 
Postnuclear RNA was extracted from cerebra or 
cerebella of fetal, newborn, lo-day-old, 30-day-old 
and adult rats by the phenol-chloroform extraction 
procedure as described [4]. Guanidinium chloride 
extraction of rat total cerebellar RNA was also car- 
ried out [5]. Poly(A) RNA was isolated from post- 
nuclear RNA or total cerebellar RNA by oligo(dT)- 
cellulose chromatography [6]. 
2.4. Translation of poly(A) RNA in a rabbit 
reticulocyte lysate cell-free system and 
analysis of the translation products 
In vitro translation was carried out in a nuclease- 
treated reticulocyte lysate cell-free system with 
cerebellar poly(A) RNA as described [7,8]. mRNA- 
dependent incorporation of [35S]methionine (1000 
Ci/mmol, Amersham, England) into trichloroacetic 
acid-insoluble proteins was determined using an 
aliquot of the translation products. An aliquot was 
applied to SDS-PAGE (12.5%) to examine the 
[35S]methionine incorporation pattern into total 
proteins. Furthermore, to an aliquot of the transla- 
tion products, anti-spot 35 protein antiserum and 
spot 35 protein were added and then im- 
munoprecipitates were applied on SDS-PAGE or 
two-dimensional PAGE followed by fluorography. 
These procedures have been detailed in [8]. 
3. RESULTS 
3.1. Characteristics of spot 35 protein and 
its antiserum 
Purified spot 35 protein shows a single band 
with M, around 27000 in comparison with M, 
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Fig. 1. Two-dimensional gel electrophoresis of spot 35 
protein. The second dimensional gel was 10%. 
marker proteins. Furthermore, two-dimensional 
gel electrophoretic analysis of purified spot 35 pro- 
tein reveals that this protein shows a single spot 
with M, 27 000 and ~15.3 (fig. 1). Other properties 
have been described in [2]. During the course of 
the studies on S-100 protein and calmodulin we us- 
ed 45Ca-binding assay for identification of these 
proteins. Then we applied this assay procedure for 
the studies of our purified proteins. Fig.2 shows 
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Fig.2. 45Ca autoradiography of spot 35 protein. 
Experimental procedures are described in section 2. (1) 
Bovine brain calmodulin, (2) rat spot 35 protein, (3) 
bovine spot 35 protein, (4) molecular mass markers. 
Volume 188, number 1 FEBS LETTERS August 1985 
that spot 35 proteins purified from rat and bovine 
cerebella are Ca-binding proteins. Ouchterlony 
double diffusion analysis shows that antisera 
against this protein gave the precipitin line to the 
antigen and cerebellar soluble protein fraction, but 
did not react with the soluble protein fractions of 
cerebrum, brain stem and liver (not shown). 
3.2. Biosynthesis of spot 35 protein in a 
reticulocyte lysate cell-free system 
Translation of poly(A) RNA from developing 
and adult rat brains showed incorporation of 
[35S]methionine into polypeptides with hetero- 
geneous molecular mass values which spanned 
about 100 kDa. Endogenous incorporation of 
[35S]methionine into the proteins was very low. 
Specific immunoprecipitation of spot 35 protein 
synthesized in vitro was done as described in sec- 
tion 2 and the precipitates were examined by SDS- 
PAGE and fluorog,raphy or by two-dimensional 
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gel electrophoresis, followed by fluorography. 
Fig.3a demonstrates the one-dimensional SDS gel 
electrophoretic pattern of total translation prod- 
ucts (lane 1) and the labeled band of immuno- 
precipitated protein with similar I%& to spot 35 
(lane 2). Fig. 3b also shows that the labeled spot of 
immunoprecipitated protein possesses imilar pl 
and M, values to the authentic spot 35 by two- 
dimensional gel electrophoresis. Further, we could 
purify mRNA for spot 35 protein from rat cere- 
bellar free polysomes using an immunoadsorption 
procedure 191 (unpublished). Therefore, it is clear 
that spot 35 protein was synthesized in our system. 
3.3. Developmental changes in the mRNA level 
for spot 35 protein 
Poly(A) RNA was extracted from the cerebella 
of newborn, lo-, 30- and 90-day-old rats and 
translated in a reticulocyte lysate system, Labeled 
spot 35 protein was immunoprecipitated from 
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Fig.3. Fluorogram of translation products in a reticulocyte iysate directed with adult rat cerebellar mRNA. 
Experimental conditions are described in section 2. (a) One-dimensional gel electrophoresis of total translation products 
(lane 1) and the immunoprecipitates from the total translation products (lane 2), and (b) two-dimensional gel 
electrophoresis of the immunoprecipitates from the translation products. 
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equal counts of the translational products as 
described in section 2 and was examined on SDS- 
PAGE, followed by fluorography. Fig.4 shows 
that one labeled band corresponding to spot 35 
protein was clearly found in lo-90-day-old rats. 
The density of this band increased rapidly with the 
development of rats after 10 days postnatal. 
Poly(A) RNA extracted from cerebral tissue was 
not translated into spot 35 protein during every 
developmental age as shown in fig.4. 
4. DISCUSSION 
In the previous study [lo], we observed the 
biosynthesis of total soluble cerebellar protein in 
cerebellar slices and in a reticulocyte lysate cell-free 
system using two-dimensional gel electrophoretic 
analysis. In that study the protein having similar pl 
and M, to spot 35 protein seemed to be synthe- 
sized, although identification with antiserum 
against it was not carried out. Morrison et al. [1 1] 
and Soreq et al. [ 121 also described the biosynthesis 
of total cerebellar protein in a cell-free system. The 
results of this paper clearly demonstrate the 
mRNA-dependent cell-free biosynthesis of spot 35 
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Fig.4. Developmental changes in the fluorogram of 
translation products. (1) Total translation products 
(500000 cpm) with cerebellar poly(A) RNA; (2-5) 
fluorogram of immunoprecipitates from the total 
translation products with cerebral poly(A) RNA; (2) 
newborn, (3) lo-day-old, (4) 30-day-old, (5) 90-day-old; 
(6-9) Fluorograms of immunoprecipitates from the total 
translation products with cerebellar poly(A) RNA: (6) 
newborn, (7) lo-day-old, (8) 30-day-old, (9) 90-day-old. 
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protein by using specific immunoprecipitation and 
SDS-PAGE or two-dimensional gel electrophoresis. 
It was further found that the levels of mRNA for 
spot 35 protein showed a great increase during 
cerebellar development. In a separate paper it was 
described that the antiserum against spot 35 pro- 
tein specifically stained Purkinje cells [2]. Further- 
more, our unpublished study revealed the ap- 
pearance of positive PAP staining of rat cerebellar 
Purkinje cells on around the third day after birth. 
These results suggest hat spot 35 protein may be 
a marker protein of maturation of Purkinje cells. 
The recent introduction of the new 45Ca-binding 
assay procedure showed that this protein is a Ca- 
binding protein, Further, our neurophysiological 
study revealed the involvement of this protein in 
modulation of Purkinje cell activity of the rat 
cerebellum [ 131. 
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